It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Recently identified tumor genomic alterations are associated with altered tumor immune microenvironments and therapeutic outcomes. These studies beg the question: are there other genomic variations altering the immune microenvironment in tumors that can provide insight into mechanisms of immune evasion? Current approaches to estimate immunity in bulk RNAseq from tumors include gene set enrichment and cellular deconvolution. In contrast, our new software package RIGATonI utilizes a gene agnostic approach to classify immune cell infiltration in tumors. Using pathologist reviewed histology slides and paired bulk RNA sequencing expression data, we trained a machine learning algorithm to detect inflamed and non-inflamed immune microenvironments. RIGATonI enables identifcation of candidate genomic alterations associated with immune infilration in subsets of cancer through evaluation of various features including gene expression, genomic alterations, pathologist-classified tumors, clinical outcomes, and protein validation. In addition to immune infiltrate classification, RIGATonI leverages a novel algorithm using known protein-protein interactions for prediction of gain-of-function and loss-of-function for genomic alterations to improve filtering of genomic alteration candidats. Applying these two novel methods, we analyzed all genomic alterations present in The Cancer Genome Altas and visualized promising results with R shiny for public use. Thus, we present our R tool and online database for Rapid Identification of Genomic Alterations in Tumors affecting lymphocyte Infiltration (RIGATonI).
Competing Interest Statement
The authors have declared no competing interest.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer